Medical device and MedTech insights, news, tips and more

MedWand Solutions Receives FDA 510k Clearance

August 22, 2022


MedWand Solutions, Inc. is pleased to announce that the company’s groundbreaking MedWand device and VirtualCare ecosystem is commercially available to enable clinical exams with its comprehensive care solutions. Poised to transform the current capabilities of telemedicine, MedWand is offering various kits including: the MedWand Evaluation Kit, the MedWand Mobile Clinic, and the MedWand Remote Clinic. By facilitating a more comprehensive assessment of a patient’s health and an extensive remote diagnosis, MedWand provides the crucial missing link in the delivery of telemedicine. To request a demo today visit

“I am happy to share that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to the MedWand,” shared MedWand CEO and Co-Founder, Robert Rose. “As a company dedicated to advancing access to quality healthcare, we are proud to offer our innovative solutions to medical facilities worldwide to help lower operating costs, improve health equity, and ultimately save lives.”

MedWand has already received widespread interest within the telehealth industry and medical community. The award-winning company is currently rolling out its solution through strategic partnerships with major health systems, physician groups, and telehealth companies with the below kits:

  • MedWand Evaluation Kit– Designed for clinical evaluation of the MedWand device and ecosystem.
  • MedWand Mobile Clinic– Designed for physician or home visits and remote patient monitoring applications.
  • MedWand Remote Clinic– Designed for remote / regional clinics, transport, and industrial application.

*Prices start as low as $120/month including all hardware, software, and cloud services. Please contact MedWand Sales to request a complimentary quotation.

“When it comes to medical diagnostics, clinical accuracy is not just important, but critical, and MedWand’s goal has always been to be the most clinically-dependable telemedicine device in the world,” shared Samir Qamar, MD, Co-Founder and Chief Medical Officer. “With FDA clearance, clinicians and patients everywhere can trust MedWand’s vitals and remote examination tools, and experience telemedicine on an entirely new level.”

Transforming the current understanding of telemedicine, MedWand combines multiple clinically accurate vitals sensors and an Ultra-HD resolution camera into one, handheld, lightweight device. Data collected include core temperature, blood oxygen saturation and pulse rate, heart, lung and abdominal auscultations, electrocardiogram*, and high definition otoscopic, oropharynx, and dermatoscopic exam images. MedWand VirtualCare Cliniccan also provide blood pressure, glucometer, spirometry, weight, and body mass data by instantly connecting to FDA-cleared third party tools.

MedWand’s Virtual Care Clinic software provides a link between MedWand devices and existing Electronic Medical Record and Practice Management Software. Supporting single password sign-in, accepting externally scheduled appointments, and exchanging patient data with the EMR, the Virtual Care Clinic software goes beyond video consultation by offering a comprehensive remote exam. Delivering a unique combination of video consultation, live monitoring,and remote clinical-grade vitals capture, MedWand also provides a platform for future AI based vitals data analysis to enable cost efficient and comprehensive telemedicine services for medical facilities worldwide.

The ergonomic MedWand device and its associated software applications were created by a team of physicians and medical device engineers to enhance the quality and accessibility of health care services for clinicians and patients, regardless of physical location. The company offers MedWand and Virtual Care Clinic solutions for applications that include hospitals, field clinics, nursing homes, schools, and workplaces, wherever Internet access is available.

When patient care depends on telemedicine, choose MedWand. For more information on MedWand visit To schedule a private demonstration or to request a formal product quotation please contact MedWand at For more information on MedWand visit

*Electrocardiogram feature is available in select countries, currently awaiting US FDA 510(k) clearance.

About MedWand Solutions, Inc

MedWand Solutions, Inc. is FDA-approved device and ecosystem that delivers digital healthcare technologies to enhance the accessibility and quality of healthcare services for clinicians and patients, regardless of location. MedWand was created by a team of physicians and engineers to enhance the quality and accessibility of health care services regardless of physical location. The company will offer its MedWand device, Virtual Care Clinic, and cloud based universal AI diagnostic platform for a wide range of applications that include hospitals, field clinics, nursing homes, schools, and workplaces, wherever Internet access is available.

See Full Press Release at the Source: MedWand™ Solutions, Inc. is Transforming Telemedicine with Award-Winning Device and VirtualCare Platform, Now Available

Press Release by: MedWand™ Solutions, Inc.

Legacy MedSearch has more than 35 years of combined experience recruiting in the medical device industry. We pride ourselves on our professionalism and ability to communicate quickly and honestly with all parties in the hiring process. Our clients include both blue-chip companies and innovative startups within the MedTech space. Over the past 17 years, we have built one of the strongest networks of device professionals ranging from sales, marketing, research & , quality & regulatory, project management, field service, and clinical affairs.

We offer a variety of different solutions for hiring managers depending on the scope and scale of each individual search. We craft a personalized solution for each client and position with a focus on attracting the best possible talent in the shortest possible time frame.

Are you hiring?
Contact us to discuss partnering with Legacy MedSearch on your position.

More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.